{
    "2020-02-06": [
        [
            {
                "time": "2023-03-15",
                "original_text": "J&J Brand Most Valuable Among Pharmaceutical Companies",
                "features": {
                    "keywords": [
                        "J&J",
                        "Brand",
                        "Valuable",
                        "Pharmaceutical"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Bristol-Myers' (BMY) Q4 Earnings & Revenues Beat Estimates",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Q4",
                        "Earnings",
                        "Revenues",
                        "Beat",
                        "Estimates"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Glaxo (GSK) Lags Q4 Earnings & Revenue Estimates, Stock Down",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "GSK",
                        "Lags",
                        "Q4",
                        "Earnings",
                        "Revenue",
                        "Estimates",
                        "Stock",
                        "Down"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Bristol-Myers earnings rise due to Celgene deal",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "earnings",
                        "rise",
                        "Celgene",
                        "deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}